Concepedia

Insulin Management

Insulin Management is a clinical framework within medication management that systematically governs the administration, monitoring, and adjustment of insulin therapies to optimize glycemic control in individuals with diabetes.

2.8K

Publications

158.9K

Citations

11.3K

Authors

3.1K

Institutions

Publications per year

2017–2026

635

Parents

Publications

2.8K

Intensive Insulin Therapy in Critically Ill Patients

Greet Van den Berghe, Pieter Wouters, Frank Weekers et al. · New England Journal of Medicine · 2001 · 10K citations · Full text

, , +10

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

Yasuo Ohkubo, Hideki Kishikawa, Eiichi Araki et al. · Diabetes Research and Clinical Practice · 1995 · 3.1K citations

, , +15

Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia

Origin Trial Investigators · New England Journal of Medicine · 2012 · 1.6K citations · Full text

, , +14

Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*

Greet Van den Berghe, Pieter Wouters, Roger Bouillon et al. · Critical Care Medicine · 2003 · 1.5K citations

, , +17

Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus

K. Malmberg · BMJ · 1997 · 1.3K citations · Full text

, , +15

1–5 of 2.8K

Authors

11.3K

  1. JR
    Julio Rosenstock

    Dallas Diabetes Research Center, United States

    29 publications · 4.4K citations

    26

    h-index

  2. PH
    Philip Home

    Newcastle University, United Kingdom

    27 publications · 3.4K citations

    23

    h-index

  3. RM
    Richard M. Bergenstal

    Park Nicollet Clinic, United States

    25 publications · 4.3K citations

    22

    h-index

  4. BW
    Bruce W. Bode

    Atlanta Diabetes Associates, United States

    22 publications · 3K citations

    21

    h-index

  5. GB
    Geremia B. Bolli

    University of Perugia, Italy

    22 publications · 2K citations

    19

    h-index

1–5 of 11.3K

Institutions

3.1K

  1. Novo Nordisk (Denmark)

    Copenhagen, Denmark

    60 h-index

    247 publications

    21.9K citations

  2. Harvard University

    Cambridge, United States

    38 h-index

    172 publications

    14K citations

  3. Eli Lilly (United States)

    Indianapolis, United States

    32 h-index

    221 publications

    16.2K citations

  4. Newcastle University

    Newcastle upon Tyne, United Kingdom

    29 h-index

    73 publications

    5.6K citations

  5. Sanofi (United States)

    Bridgewater, United States

    27 h-index

    79 publications

    2.9K citations

  6. Sanofi (France)

    Paris, France

    27 h-index

    71 publications

    3.7K citations

  7. Yale University

    New Haven, United States

    26 h-index

    106 publications

    12.8K citations

  8. Inserm

    Paris, France

    25 h-index

    72 publications

    6.3K citations

1–8 of 3.1K

Venues

  1. Diabetes Care

    228 publications · 24.1K citations

    87

    h-index

  2. Diabetic Medicine

    129 publications · 7.7K citations

    48

    h-index

  3. Diabetes Obesity and Metabolism

    108 publications · 5.5K citations

    44

    h-index

  4. Diabetes Technology & Therapeutics

    126 publications · 4.5K citations

    36

    h-index

  5. Diabetes Research and Clinical Practice

    97 publications · 6.9K citations

    35

    h-index

1–5